I-Mab (IMAB)
$1.06 -$0.02 (-1.89%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$85.74M -
Day's Range
$1.02 - $1.08 -
Volume
293,275 -
52 Week Low / High
$0.90 - $2.54 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
IMAB's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $29.11
- Target Price
Company News
-
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer — Jun 6th, 2024
ROCKVILLE, Md., June 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced the appoint...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$